Efficacy of zinc supplementation in preventing acute hepatitis in Long-Evans Cinnamon rats

Liver International

Volumn 25, Issue 4, 2005, Pages 888-895

  Medici, Valentina ^a   Sturniolo, Giacomo Carlo ^a   Santon, Alessandro ^a   D'Incà, Renata ^a   Bortolami, Marina ^a   Cardin, Romilda ^a   Basso, Daniela ^a   Albergoni, Vincenzo ^a   Irato, Paola ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

LEC rats; Metallothionein; Wilson disease; Zinc

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; COPPER; COPPER EXPORTING ADENOSINE TRIPHOSPHATASE; GLUCOSE; IRON; METALLOTHIONEIN; ZINC ACETATE;

ACUTE HEPATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ABSORPTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG LIVER LEVEL; DRUG TISSUE LEVEL; EXPERIMENTAL DESIGN; FEEDING; IRON METABOLISM; KIDNEY; LIVER INJURY; MALE; NONHUMAN; RAT; RAT STRAIN; STOMACH INTUBATION; SUPPLEMENTATION; SYMPTOMATOLOGY; WILSON DISEASE;

ADMINISTRATION, ORAL; ANIMALS; DEOXYGUANOSINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATITIS, ANIMAL; HEPATITIS, TOXIC; IRON; KIDNEY; LIVER; MALE; METALLOTHIONEIN; PROTECTIVE AGENTS; RATS; RATS, INBRED LEC; ZINC; ZINC ACETATE;

EID: 22844451248     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01108.x     Document Type: Article

References (31)

1. Wu J, Forbes JR, Chen SH, et al. The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Nat Genet 1994; 7: 541-5.
2. Sasaki N, Hayashizaki Y, Muramatsu M, et al. The gene responsible for LEC hepatitis, located on rat chromosome 16, is the homologue to the human Wilson disease gene. Biochem Biophys Res Comm 1994; 202: 512-8.
3. Mori M, Hattori A, Sawaki M, et al. The LEC rat: a model for human hepatitis, liver cancer, and much more. Am J Pathol 1995; 144: 200-4.
4. Ohhira M, Ono M, Ohhira M, et al. Changes in free radical-metabolizing enzymes and lipid peroxides in the liver of Long-Evans with cinnamon-like coat colour rats. J Gastroenterol 1995; 30: 619-23.
5. Sugawara N, Katakura M, Li D, et al. Role of hepatic copper-metallothionein on liver function of Long-Evans Cinnamon rats with a new mutation causing hereditary hepatitis. Res Comm Chem Path Pharm 1994; 83: 349-58.
6. Yamamoto H, Hirose K, Hajasaki L, et al. Mechanisms of enhanced lipid peroxidation in the liver of Long-Evans cinnamon (LEC) rats. Arch Toxicol 1999; 73: 457-64.
7. Yamamoto H, Watanabe T, Mizuno H, et al. In vivo evidence for accelerated generation of hydroxyl radicals in liver of Long-Evans Cinnamon (LEC) rats with acute hepatitis. Free Radic Biol Med 2001; 30: 547-54.
8. Sokol RJ, Twedt D, McKim J, et al. Oxidant injury to hepatic mitochondria in patients with Wilson disease and Bedlington terriers with copper toxicosis. Gastroenterology 1994; 107: 1788-98.
9. Kato J, Kobune M, Kohgo Y, et al. Hepatic iron deprivation prevents spontaneous development of fulminant hepatitis and liver cancer in Long-Evans Cinnamon rats. J Clin Invest 1996; 98: 923-9.
10. Yamamoto F, Kasai H, Togashi Y, et al. Elevated level of 8-hydroxydeoxyguanosine in DNA liver, kidneys and brain of Long-Evans Cinnamon rats. Jpn J Cancer Res 1993; 84: 508-11.
11. Fraga CG, Shigenaga MK, Park JW, et al. Oxidative damage to DNA during aging: 8-hydroxy-2-deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci USA 1990; 87: 4533-7.
12. Kille P, Hemmings A, Lunney EA. Memory of metallothionein. Biophys Acta 1994; 1205: 151-61.
13. Hamer DH. Metallothionein. Ann Rev Biochem 1986; 55: 913-51.
14. Santon A, Irato P, Medici V, et al. Effect and possible role of Zn treatment in LEC rats, an animal model of Wilson's disease. Biochim Biophys Acta 2003; 1637: 91-7.
15. Medici V, Santon A, Sturniolo GC, et al. Metallothionein and antioxidant enzymes in Long-Evans Cinnamon rats treated with zinc. Arch Toxicol 2002; 76: 509-16.
16. Tietz NW, Clinical Guide to Laboratory Tests. Philadelphia: W.B. Saunders, 1990.
17. Scheuammer AMV, Cherian MG. Quantification of metallothionein by silver saturation. Methods Enzymol 1991; 203: 75-83.
18. Brewer GJ, Dick RD, Yuzbasiyan-Gurkan V, et al. Treatment of Wilson disease with zinc: XIII. Therapy with zinc in presymptomatic patients from the time of diagnosis. J Lab Clin Med 1994; 123: 849-58.
19. Brewer JG, Dick RD, Johnson VD, et al. Treatment of Wilson's disease with zinc. XV Long-term follow-up studies. J Lab Clin Med 1998; 132: 264-8.
20. Brewer GJ, Dick RD, Johnson VD, et al. Treatment of Wilson's disease with zinc. XVI: treatment during pediatric years. J Lab Clin Med 2001; 137: 191-8.
21. Brewer GJ, Johnson VD, Dick RD, et al. Treatment of Wilson's disease with zinc. XVII; treatment during pregnancy. Hepatology 2000; 31: 364-70.
22. Hill GM, Brewer GJ, Prasad AS, et al. Treatment of Wilson's disease with zinc: I Oral zinc therapy regimens. Hepatology 1987; 7: 522-8.
23. Powell SR. The antioxidant properties of zinc. J Nutr 2000; 130: 1447S-54S.
24. Davis SR, Samuelson DA, Cousins RJ. Metallothionein expression protects against carbon tetrachloride-induced hepatotoxicity, but overexpression and dietary zinc supplementation provide no further protection in metallothionein transgenic and knockout mice. J Nutr 2001; 131: 215-22.
25. Sturniolo GC, Mestriner C, Irato P, et al. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients. Am J Gastroenterol 1999; 94: 334-8.
26. Santon A, Sturniolo GC, Albergoni V, et al. Metallothionein-1 and metallothionein-2 gene expression and localization of apoptotic cells in Zn-treated LEC rat liver. Histochem Cell Biol 2003; 119(4): 301-8.
27. Bruewer M, Schimd KW, Krieglstein N, et al. Metallothionein: early marker in the carcinogenesis of ulcerative colitis associated colorectal carcinoma. World J Surg 2002; 26: 726-31.
28. Iwata M, Takebayashi T, Ohta H, et al. Zinc accumulation and metallothionein gene expression in the proliferating epidermis during wound healing in mouse skin. Histochem Cell Biol 1999; 112: 283-90.
29. Kobusch AB, Bock KW. Zinc increases EGF-stimulated DNA synthesis in primary mouse hepatocytes. Studies in tumor promoter-treated cell cultures. Biochem Pharmacol 1990; 39: 555-8.
30. Brewer GJ, Merajver SD. Cancer therapy with tetrathiomolybdate: antiangiogenesis by lowering body copper: a review. Integr Cancer Ther 2002; 1(4): 327-37.
31. Yoshiji H, Kuriyama S, Yoshii J, et al. The copper chelating agent, trientine, attenuates liver enzyme-altered preneoplastic lesions in rats by angiogenesis suppression. Oncol Rep 2003; 10(5): 1369-73.